For research use only. Not for therapeutic Use.
SHU 9119(Cat No.:P000226)is an experimental drug being researched for its potential as an anticancer agent. It is a synthetic compound that targets specific proteins involved in the regulation of cell survival and growth, particularly in tumor cells. By modulating these pathways, SHU 9119 may help inhibit the growth and spread of certain cancers. Preclinical studies have shown promising results, but its safety and effectiveness in human trials are still under investigation. If successful, SHU 9119 could provide a new treatment option for various cancer types, especially those resistant to existing therapies.
Catalog Number | P000226 |
CAS Number | 168482-23-3 |
Molecular Formula | C54H71N15O9 |
Purity | ≥95% |
Target | Neuronal Signaling |
Solubility | Soluble to 0.20 mg/ml in water |
Storage | Store at -20C |
IUPAC Name | (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-9-(naphthalen-2-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxamide |
InChI | InChI=1S/C54H71N15O9/c1-3-4-15-40(63-31(2)70)48(73)69-45-27-46(71)59-21-10-9-17-39(47(55)72)64-51(76)43(25-35-28-61-38-16-8-7-14-37(35)38)67-49(74)41(18-11-22-60-54(56)57)65-50(75)42(24-32-19-20-33-12-5-6-13-34(33)23-32)66-52(77)44(68-53(45)78)26-36-29-58-30-62-36/h5-8,12-14,16,19-20,23,28-30,39-45,61H,3-4,9-11,15,17-18,21-22,24-27H2,1-2H3,(H2,55,72)(H,58,62)(H,59,71)(H,63,70)(H,64,76)(H,65,75)(H,66,77)(H,67,74)(H,68,78)(H,69,73)(H4,56,57,60)/t39-,40-,41-,42+,43-,44-,45-/m0/s1 |
InChIKey | GGYWLZFXFKFWKL-XOJVSUSESA-N |
SMILES | CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC2=CN=CN2)CC3=CC4=CC=CC=C4C=C3)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N)NC(=O)C |